<?xml version="1.0" encoding="UTF-8"?>
<p>Some 
 <italic>in vitro</italic> studies and clinical trials investigated the efficacy of CQ or HCQ for different viruses, especially HIV.
 <sup>
  <xref rid="bibr33-1759720X20947296" ref-type="bibr">33</xref>,
  <xref rid="bibr34-1759720X20947296" ref-type="bibr">34</xref>
 </sup> Four clinical trials showed positive results of HIV control, either in the reduction of immune activation or lowering the vertical transmission.
 <sup>
  <xref rid="bibr35-1759720X20947296" ref-type="bibr">35</xref>
  <xref rid="bibr36-1759720X20947296" ref-type="bibr"/>
  <xref rid="bibr37-1759720X20947296" ref-type="bibr"/>–
  <xref rid="bibr38-1759720X20947296" ref-type="bibr">38</xref>
 </sup> However, another two trials (one RCT, one single-arm) revealed no efficacy.
 <sup>
  <xref rid="bibr39-1759720X20947296" ref-type="bibr">39</xref>,
  <xref rid="bibr40-1759720X20947296" ref-type="bibr">40</xref>
 </sup> As for dengue,
 <sup>
  <xref rid="bibr41-1759720X20947296" ref-type="bibr">41</xref>
  <xref rid="bibr42-1759720X20947296" ref-type="bibr"/>
  <xref rid="bibr43-1759720X20947296" ref-type="bibr"/>–
  <xref rid="bibr44-1759720X20947296" ref-type="bibr">44</xref>
 </sup> chikungunya,
 <sup>
  <xref rid="bibr45-1759720X20947296" ref-type="bibr">45</xref>
  <xref rid="bibr46-1759720X20947296" ref-type="bibr"/>–
  <xref rid="bibr47-1759720X20947296" ref-type="bibr">47</xref>
 </sup> influenza A viruses,
 <sup>
  <xref rid="bibr48-1759720X20947296" ref-type="bibr">48</xref>
  <xref rid="bibr49-1759720X20947296" ref-type="bibr"/>
  <xref rid="bibr50-1759720X20947296" ref-type="bibr"/>–
  <xref rid="bibr51-1759720X20947296" ref-type="bibr">51</xref>
 </sup> and HCV,
 <sup>
  <xref rid="bibr52-1759720X20947296" ref-type="bibr">52</xref>,
  <xref rid="bibr53-1759720X20947296" ref-type="bibr">53</xref>
 </sup> paradoxical outcomes were found in the literature. Therefore, the utilization of CQ in these viral diseases still needs further investigation.
</p>
